The aim of the mobile app PatientPartner is to increase patients’ adherence to treatments and, in particular, to taking certain medications. The results have been very positive, resulting in increases in the monitoring of the treatments by 37%, an increase of 24% in the monitoring of diets and of 14% in the practice of physical exercise.
In the specific case of diabetes, independent clinical trials approved by the Institute for Biomedical Research (IBR) showed that after using PatientPartner there was a considerable increase in adherence to treatment in 100 patients with this pathology. This study showed an increase in compliance with the medication from 58% to 95%, and even the haemoglobin A1c test, which indicates the level of sugar in the blood, decreased from 10.7% to 9.7%.
Interestingly, this app is developed by explaining the story of a fictitious patient, without making reference to any particular disease. The user can customise it and direct the patient to improve the health of the character by following certain guidelines.
In short, thanks to the use of PatientPartner, users do more exercise, adopt better eating habits and adhere better to treatments. In this way, they are more autonomous in the care of their health, avoiding relapses and readmissions to hospitals, managing to reduce health care expenses and contributing to the achievement of a more efficient and sustainable health care system.
Without a doubt, these apps are the future of the mHealth technology: a sector in full expansion. Additionally, new and better health apps are emerging that help patients to deal with certain pathologies and diseases better. These applications succeed in bringing the specialised information on diseases, drugs or treatments closer to both patients and professionals.